Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium

Psychopharmacology

Volumn 179, Issue 2, 2005, Pages 447-451

  Himmerich, Hubertus ^a   Koethe, Dagmar ^a   Schuld, Andreas ^b   Yassouridis, Alexander ^a   Pollmächer, Thomas ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b KLINIKUM INGOLSTADT   (Germany)

Author keywords

Carbamazepine; Leptin; Lithium; TNF; Weight

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CYTOKINE; LEPTIN; LITHIUM; MOOD STABILIZER; NORTRIPTYLINE; PAROXETINE; REBOXETINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIDE EFFECT; WEIGHT GAIN;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; BODY MASS INDEX; BODY WEIGHT; CARBAMAZEPINE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LEPTIN; LITHIUM CARBONATE; MALE; MIDDLE AGED; MOOD DISORDERS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17644392420     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2038-9     Document Type: Article

References (31)

1. Atmaca M, Kuloglu M, Tezcan E, Ustundag B (2002) Weight gain and serum leptin levels in patients on lithium. Neuropsychobiology 46:67-69
2. Baptista T, Beaulieu S (2002) Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs? Can J Psychiatry 47:742-749
3. Baptista T, Teneud L, Contreras Q, Alastre T, Burguera JL, de Burguera M, de Baptista E, Weiss S, Hernandez L (1995) Lithium and body weight gain. Pharmacopsychiatry 28:35-44
4. Bauer MS, Mitchner L (2004) What is a "mood stabilizer"? An evidence-based response. Am J Psychiatry 161:3-18
5. Berghöfer A, Kossmann B, Müller-Oerlinghausen B (1996) Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years. Acta Psychiatr Scand 93:349-354
6. Corman CL, Leung NM, Guberman AH (1997) Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. Can J Neurol Sci 24:240-244
7. Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kuhn M, Schuld A, Pollmächer T (1999) Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 33:407-418
8. Himmerich H, Schuld A, Haack M, Kaufmann C, Pollmächer T (2004) Early prediction of changes in weight during six weeks of treatment with antidepressants. J Psychiatr Res 38:485-489
9. Hinze-Selch D, Schuld A, Kraus T, Kühn M, Uhr M, Haack M, Pollmächer T (2000) Effects of antidepressants on weight and on the plasma levels of leptin, TNF- and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology 23:13-19
10. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91
11. Kraus T, Haack M, Schuld A, Hinze-Selch D, Kühn M, Uhr M, Pollmächer T (1999) Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 156: 312-314
12. Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D, Pollmächer T (2002) Body weight, the tumor necrosis factor system and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry 35:220-225
13. Lampl Y, Eshel Y, Rapaport A, Sarova-Pinhas I (1991) Weight gam, increased appetite, and excessive food intake induced by carbamazepine. Clin Neuropharmacol 14:251-255
14. Maes M, Song C, Lin AH, Pioli R, Kenis G, Kubera M, Bosmans E (1999) In vitro immunoregulatory effects of lithium in healthy volunteers. Psychopharmacology 143:401-407
15. Malhi GS, Mitchell PB, Caterson I (2001) "Why getting fat, Doc?" Weight gain and psychotropic medications. Aust NZ J Psychiatry 35:315-321
16. McIntyre RS, Mancini DA, Basile VS, Srinivasan J, Kennedy SH (2003) Antipsychotic-induced weight gain: bipolar disorder and leptin. J Clin Psychopharmacol 23:323-327
17. Melkersson K, Dahl ML (2004) Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. Drugs 64:701-723
18. Mendlewicz J, Souery D, Rivelli SK (1999) Short-term and long-term treatment for bipolar patients: beyond the guidelines. J Affect Disord 55:79-85
19. Nemeroff CB (2003) Safety of available agents used to treat bipolar disorder: focus on weight gain. J Clin Psychiatry 64:532-539
20. Pollmächer T, Hinze-Selch D, Mullington J (1996) Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol 16:403-409
21. Pollmächer T, Schuld A, Kraus T, Haack M, Hinze-Selch D (2001) Zur klinischen Relevanz der Wirkung von Clozapin auf die Freisetzung von Zytokinen und löslichen Zytokinrezeptoren. Fortschr Neurol Psychiatr 69(Suppl 2):65-74
22. Post RM, Denicoff KD, Frye MA, Dunn RT, Leverich GS, Osuch E, Speer A (1998) A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century. Neuropsychobiology 38:152-166
23. Schou M, Baastrup PC, Grof P, Weiss P, Angst PJ (1970) Pharmacological and clinical problems of lithium prophylaxis. Br J Psychiatry 116:615-619
24. Schuld A, Kraus T, Haack M, Hinze-Selch D, Kühn M, Pollmächer T (2000) Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophr Res 102:1-3
25. Schwartz MW, Woods SC, Porte DJ, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661-671
26. Vasudev K, Goswami U, Kohli K (2000) Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psychopharmacology 150:15-23
27. Vendsborg PB, Bech P, Rafaelsen OJ (1976) Lithium treatment and weight gain. Acta Psychiatr Scand 53:139-147
28. Vestergaard P, Amdisen A (1981) Lithium treatment and kidney function. A follow-up study of 237 patients in long-term treatment. Acta Psychiatr Scand 63:333-345
29. Walden J, Normann C, Langosch J, Grunze H (1999) Wirksamkeitspradiktoren fur Phasenprophylaktika (Stimmungsstabilisierer) bei bipolaren affektiven Störungen. Fortschr Neurol Psychiatr 67:75-80
30. Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP (2004) Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry 184:58-62
31. Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmächer T (2003) Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 37:193-220